2011 Japanese Society for Dialysis Therapy Guidelines for the Treatment of Hepatitis C Virus Infection in Dialysis Patients

被引：24
|
作者：
Akiba, Takashi [1 ]
Hora, Kazuhiko [1 ]
Imawari, Michio [1 ]
Sato, Chifumi [1 ]
Tanaka, Eiji [1 ]
Izumi, Namiki [1 ]
Harada, Takashi [1 ]
Ando, Ryoichi [1 ]
Kikuchi, Kan [1 ]
Tomo, Tadashi [2 ]
Hirakata, Hideki [3 ]
Akizawa, Tadao [4 ]
机构：
[1] Working Grp Preparat Guidelines Treatment Hepatit, Tokyo, Japan
[2] Subcomm Preparat Guidelines, Tokyo, Japan
[3] Sci Comm, Tokyo, Japan
[4] Japanese Soc Dialysis, Tokyo, Japan
来源：
THERAPEUTIC APHERESIS AND DIALYSIS | 2012年 / 16卷 / 04期
关键词：
STAGE RENAL-DISEASE; POSITIVE HEMODIALYSIS-PATIENTS; PEGYLATED-INTERFERON ALPHA-2A; KIDNEY-TRANSPLANT CANDIDATES; LONG-TERM HEMODIALYSIS; HCV INFECTION; LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; ALANINE AMINOTRANSFERASE;
D O I：
10.1111/j.1744-9987.2012.01078.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：289 / 310
页数：22
相关论文
共 50 条
  • [31] HEPATITIS-C INFECTION IN PATIENTS ON DIALYSIS
    OWEN, WF
    SEMINARS IN DIALYSIS, 1994, 7 (05) : 360 - 368
  • [32] Hepatitis C infection in dialysis patients in Israel
    Weinstein, T
    Tur-Kaspa, R
    Chagnac, A
    Korzerts, A
    Ori, Y
    Zevin, D
    Herman, M
    Gafter, U
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2001, 3 (03): : 174 - 177
  • [33] Policy for developing clinical practice guidelines of Japanese Society for Dialysis Therapy
    Nitta K.
    Masakane I.
    Tomo T.
    Tsuchida K.
    Ikeda K.
    Ogawa T.
    Kanda E.
    Kanno Y.
    Komatsu Y.
    Taniguchi M.
    Taki F.
    Hasegawa T.
    Hanafusa N.
    Hamano T.
    Fukagawa M.
    Minakuchi J.
    Yamamoto H.
    Washida N.
    Wada T.
    Watanabe Y.
    Renal Replacement Therapy, 3 (1)
  • [34] Epidemiology of GB virus C/hepatitis G virus infection in patients on peritoneal dialysis
    Fabrizi, F
    De Vecchi, AF
    Lunghi, G
    Finazzi, S
    Bisegna, S
    Ponticelli, C
    PERITONEAL DIALYSIS INTERNATIONAL, 2002, 22 (03): : 405 - 410
  • [35] Detection of hepatitis C virus RNA in peritoneal dialysis fluid of patients with hepatitis C virus infection.
    Cusumano, A
    Poratto, F
    DelPino, N
    Fernandez, J
    Turin, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A1205 - A1205
  • [36] Impact of hepatitis C virus infection and other comorbidities on survival in patients on dialysis
    Butt, A. A.
    Skanderson, M.
    McGinnis, K. A.
    Ahuja, T.
    Bryce, C. L.
    Barnato, A. E.
    Chang, C.-C. H.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (10) : 688 - 696
  • [37] Impact of hepatitis C virus infection and other comorbidities on survival in patients on dialysis
    Butt, AA
    Skanderson, M
    McGinnis, K
    Ahuja, T
    Bryce, C
    Barnato, A
    Chang, CCH
    HEPATOLOGY, 2005, 42 (04) : 430A - 430A
  • [38] Patient survival in dialysis patients with hepatitis C virus (HCV) infection.
    StehmanBreen, C
    Gretch, D
    Johnson, RJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0978 - A0978
  • [39] HEPATITIS-C VIRUS-INFECTION IN RENAL DIALYSIS PATIENTS IN GLASGOW
    MCINTYRE, PG
    MCCRUDEN, EAB
    DOW, BC
    CAMERON, SO
    MCMILLAN, MA
    ALLISON, MEM
    BRIGGS, JD
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (03) : 291 - 295
  • [40] Combination therapy with daclatasvir and asunaprevir for dialysis patients infected with hepatitis C virus
    Sato, Ken
    Yamazaki, Yuichi
    Ohyama, Tatsuya
    Kobayashi, Takeshi
    Horiguchi, Norio
    Kakizaki, Satoru
    Kusano, Motoyasu
    Yamada, Masanobu
    WORLD JOURNAL OF CLINICAL CASES, 2016, 4 (03) : 88 - 93
12345